Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study

Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter... Ann Surg Oncol (2017) 24:2639–2645 DOI 10.1245/s10434-017-5923-2 O R I G IN AL ARTI CL E – GA STROIN TESTINA L O N C OLO G Y Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study 1 1 2 3 Kotaro Yamashita, MD , Yukinori Kurokawa, MD, FACS , Kazuyoshi Yamamoto, MD , Masashi Hirota, MD , 4 5 6 1 Ryohei Kawabata, MD , Jota Mikami, MD , Toru Masuzawa, MD , Shuji Takiguchi, MD , Masaki Mori, MD, 1 1 FACS , and Yuichiro Doki, MD 1 2 Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Surgery, Osaka National Hospital, Osaka, Japan; Department of Surgery, Toyonaka Municipal Hospital, Osaka, Japan; 4 5 Department of Surgery, Osaka Rosai Hospital, Osaka, Japan; Department of Surgery, Sakai Municipal Hospital, Osaka, Japan; Department of Surgery, Osaka Police Hospital, Osaka, Japan ABSTRACT and 62.9%, respectively. Type of gastrectomy or body Background. Curative gastrectomy followed by adjuvant weight loss at 1 month after surgery did not affect either S-1 chemotherapy for 12 months is one of the standard 12-month compliance or the cumulative continuation rate treatments for patients with pathological http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study

Loading next page...
 
/lp/springer_journal/risk-factors-for-poor-compliance-with-adjuvant-s-1-chemotherapy-for-AxAxK15MAC
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-017-5923-2
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2017) 24:2639–2645 DOI 10.1245/s10434-017-5923-2 O R I G IN AL ARTI CL E – GA STROIN TESTINA L O N C OLO G Y Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study 1 1 2 3 Kotaro Yamashita, MD , Yukinori Kurokawa, MD, FACS , Kazuyoshi Yamamoto, MD , Masashi Hirota, MD , 4 5 6 1 Ryohei Kawabata, MD , Jota Mikami, MD , Toru Masuzawa, MD , Shuji Takiguchi, MD , Masaki Mori, MD, 1 1 FACS , and Yuichiro Doki, MD 1 2 Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Surgery, Osaka National Hospital, Osaka, Japan; Department of Surgery, Toyonaka Municipal Hospital, Osaka, Japan; 4 5 Department of Surgery, Osaka Rosai Hospital, Osaka, Japan; Department of Surgery, Sakai Municipal Hospital, Osaka, Japan; Department of Surgery, Osaka Police Hospital, Osaka, Japan ABSTRACT and 62.9%, respectively. Type of gastrectomy or body Background. Curative gastrectomy followed by adjuvant weight loss at 1 month after surgery did not affect either S-1 chemotherapy for 12 months is one of the standard 12-month compliance or the cumulative continuation rate treatments for patients with pathological

Journal

Annals of Surgical OncologySpringer Journals

Published: Jun 12, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off